Article
Fragment length analysis screening for detection of CEBPA mutations in intermediate-risk karyotype acute myeloid leukemia.
Annals of hematology - 1 Jan 2012
Fuster Oscar, Barragán Eva, Bolufer Pascual, Such Esperanza, Valencia Ana, Ibáñez Mariam, Dolz Sandra, de Juan Inmaculada, Jiménez Antonio, Gómez Maria Teresa, Buño Ismael, Martínez Joaquín, Cervera José, Montesinos Pau, Moscardó Federico, Sanz Miguel Ángel
Abstract excerpt
During last years, molecular markers have been increased as prognostic factors routinely screened in acute myeloid leukemia (AML). Recently, an increasing interest has been reported in introducing to clinical practice screening for mutations in the CCAAT/enhancer-binding protein α (CEBPA) gene in AML, as it seems to be a good prognostic factor. However, there is no reliable established method for assessing CEBPA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.